Johnson Matthey, the UK speciality chemicals company, has fought off competition from two private equity firms to emerge as frontrunner to buy the catalysts division of Akzo Nobel, the Swedish chemicals firm, in a deal worth up to €700m ($848m).

According to bankers close to the deal, Johnson Matthey has fought off competition from Permira and Carlyle, and is poised to enter exclusive negotiations with Akzo Nobel.